chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 01/24/2023, I started with a slightly scratchy throat in the evening. The next day, I felt slightly congested. I had some nasal congestion. I did not sleep well Wednesday night. Thursday, I did not feel well, but it wasn't too bad. I probably had a slight fever because I had slight chills. I considered all of it to be allergy related. The pollen was very high in my area at that time and my mother also had congestion and coughing. I drove home from out of town that Thursday. I went to bed early that night because I was convinced, I had fever and thought it might be COVID-19. The next morning, I took an at home COVID-19 test and it was loudly positive. My mother and sister informed me that they had also tested positive. I laid around most of the day and slept. I didn't feel really bad, but not great. My temperature was up to almost 100 degrees by the time I took it. I continued to have congestion, hoarseness, some runny nose, stopped up ears, and some cough. By Sunday, I was having some tightness and burning in my throat and upper chest. The following Monday, into Tuesday, I went to the emergency room at the advice of my doctor. They did a lung x-ray, blood work, and EKG, and other testing. They determined that there was nothing wrong other than what they call the COVID-19 burn. By Tuesday night, it had gone away. It was there from Saturday-Tuesday. By Wednesday, I felt a whole lot better. I still sounded stopped up and my head still felt stopped up. The following Monday, 02/09/2023, I tested negative for COVID-19 with an at home test. I was able to return to my part time job at that point. During this time, I treated myself with DIMETAPP and TYLENOL. It probably wasn't for another full week before I felt totally normal, without congestion or fatigue.
diarrhea, fever, lethargy going for 3 days now. Not sure if this is vaccine related or some type of gastroenteritis.
On the morning of April 8, 2021, dull, achy lower back pain woke me up and did not subside throughout the day.  The next morning,  April 9, 2021 (2 weeks to the day of my 2nd Pfizer vaccine dose), I noticed a few spots on my lower left to middle torso.  The pain was increasingly unbearable.  I immediately suspected possible shingles and went to ER where I was diagnosed with shingles.  I was prescribed a 10 day dose of antiviral acyclovir along with Percocet.   As of this date, despite various OTC remedies as well as completing all medications prescribed, I still have inflammation, pain that intensifies throughout the day, as well as periodic numbness,  primarily on my left side (which was the site of the original shingles attack).
Permanent Tinnitus in left ear started 4 days after receiving the first covid vaccine. Since then, the loudness has increased.  Now, the sound is in the left ear as well as in the head.
Severe shoulder pain could not sleep on it- now severe joint pain at AJ joint with decreased ROM of RUE.
1 of 2 pts who recvd vax devel generalized urticaria; event occurred w/in 48 hrs p/vax; No office visit; tx w/DPH; no angioedema;
Redness and small bumps on my face  Rashes are itchy, and fluids on them   It started from chin now it is growing all over my face. Very uncomfortable
low grade fever; chill; muscle pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever), CHILLS (chill), MYALGIA (muscle pain) and HEADACHE (headache) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PYREXIA (low grade fever), CHILLS (chill), MYALGIA (muscle pain) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, PYREXIA (low grade fever), CHILLS (chill), MYALGIA (muscle pain) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Pt found lying on floor 10 mins after H1N1 immun. Pt states nausea, dizziness, no SOB, urticaria, skin, vitals normal. Non-febrile. Vitals 150/72 -80 - 12. 15 mins later pt states slight improvement. Parent called. Mother picked up child. 134/82 - 76 - 16 when discharged. Parent conciled on s/s of reaction to H1N1 shot and advised to seek medical care if patient's condition worsens.
Middle of right upper arm where I gave her injection (subcutaneous) felt warm and swollen. It continued to get more red and became firm like a welt, warm to touch and edematous. Approx size- 45mmX45mm.
L knee and ankle swelling, heat and severe pain. The swelling continued to spread up her leg from both joints. Pt unable to bear weight on either joint. Very fatigued. Rheumatoid factor more positive. Now patient is unable to participate in school sports.
Sore at the injection site; This is a spontaneous report received from contactable reporter (Consumer or other non HCP) from medical information team.  A 78-year-old female patient received BNT162b2 (BNT162B2), on 08Feb2021 at 10:00 as dose 2, single (Lot number: EN9581, Expiration Date: May2021) at the age of 76 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "kidney removed", start date: Oct2021 (unspecified if ongoing); "Sciatica" (unspecified if ongoing), notes: Had sciatica so bad, had to lay in bed; "Back surgery" (unspecified if ongoing), notes: had back surgery in the past; "mass in kidney and looked very cancerous" (unspecified if ongoing), notes: looked very cancerous; "Nerve block" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Oxycodone (as reported) for pain, reaction(s): "did not take the pain away", notes: Strength: 5mg, Count: Not provided, Additional lot numbers: Unknown. Vaccination history included: BNT162b2 (DOSE 1, SINGLE;  Manufacturer: Pfizer; NDC: Unknown; LOT: EL3249; Expiration Date: May2021, Dose and Route: injected into right arm; dose amount unknown, Time: around 18:00-19:00; drive-thru vaccine facility), administration date: 18Jan2021, when the patient was 76-year-old, for COVID-19 immunization, reaction(s): "sore arm at the injection site"; Shingles ("Caller and his wife had all vaccines, from shingles to whatever"). The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Sore at the injection site". ; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300032197 same patient/drug/event, different dose;US-PFIZER INC-202300032250 same patient/drug/event, different dose;US-PFIZER INC-202300032251 same patient/drug/event, different dose;US-PFIZER INC-202300030735 same patient/drug/event, different dose;
Patient is a 15 Y male presenting with concern for allergic reaction.  The patient has a history of Neonatal hemochromatosis status post liver transplant ×2, eosinophilic gastroenteritis.  He was seen in the transplant clinic today and given for immunizations around 4:30 PM.  Less than 30 minutes later, he developed swelling of his bilateral eyes, lips, coughing, sneezing, and throat tightness.  The mother gave the patient 50 mg of Benadryl and 2 puffs of albuterol.  She called the transplant clinic who recommended that the patient return to the emergency department for further evaluation.  No nausea, vomiting, abdominal pain, dizziness/presyncope, or other complaints.  Patient states that he is feeling much better at this time, although he still has some mild throat tightness still.  He has multiple allergens, but denies any exposures to them. 15-year-old male with complex past medical history presenting with symptoms concerning for anaphylaxis given involvement of multiple organ systems, normal exam here.  However given anaphylaxis diagnosis, we'll treat with IM epinephrine 0.5 mg.  I also discussed the case with the liver team and plan for Decadron today and tomorrow, Zyrtec, Zantac. 8:40 PM Patient has remained clinically stable throughout his ED course.  Family feels comfortable with discharge home.  I discussed at length with them the risk of biphasic reaction, need for prompt follow-up if it recurs.  They demonstrated good understanding.  Safe for d/c home with PCP f/u.  All questions answered, family demonstrated good understanding of discharge instructions.
Vaccinated Friday - chills, lethargic on Saturday. Large red area around injection sire from elbow to shoulder on Thursday - > chills stopped Tuesday, redness going away.
second dose two weeks after first dose; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose two weeks after first dose) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02521A and 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose two weeks after first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose two weeks after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided  No treatment medication was provided
freezing; tenderness of lymph nodes of left arm injection site underarm; woke up and threw up/again threw up; "almost passed out"; migraine; body aches; tired; shaking; woke up nauseous; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking), FEELING COLD (freezing), PRESYNCOPE ("almost passed out"), MIGRAINE (migraine) and LYMPH NODE PAIN (tenderness of lymph nodes of left arm injection site underarm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, the patient experienced TREMOR (shaking) and NAUSEA (woke up nauseous). On 06-Dec-2021 at 9:00 AM, the patient experienced FATIGUE (tired). On 06-Dec-2021 at 7:00 PM, the patient experienced MYALGIA (body aches). On 07-Dec-2021, the patient experienced PRESYNCOPE ("almost passed out") and MIGRAINE (migraine). On 07-Dec-2021 at 2:00 AM, the patient experienced VOMITING (woke up and threw up/again threw up). On an unknown date, the patient experienced FEELING COLD (freezing) and LYMPH NODE PAIN (tenderness of lymph nodes of left arm injection site underarm). At the time of the report, TREMOR (shaking), FEELING COLD (freezing), PRESYNCOPE ("almost passed out"), MIGRAINE (migraine), LYMPH NODE PAIN (tenderness of lymph nodes of left arm injection site underarm), FATIGUE (tired), MYALGIA (body aches), VOMITING (woke up and threw up/again threw up) and NAUSEA (woke up nauseous) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
On the 21st in the morning I had alternating chills and subjective fever. I did not really have fever and kept monitoring it during the day. The next day I kept with the subjective fever and the chills, went to the urgent care the next day and was tested for covid, flu and strep and it came positive for strep. I was prescribed an antibiotic and stayed home the next day since I still did not feel well.
That same evening as the shot, I began having having flu-like symptoms between 8:15 and 8:30. First was slight headache, then chills/shakes, then 102 temperature - generally miserable. I went to bed about midnight but I was so restless I went into another room to sleep. Then about 3:00 AM, it all broke, and I felt normal - just fine. I have had a shot every year for at least 20 years, but have never had any other negative reaction except in 1990 when I had a similar rection and outcome. I always thought this may happen with a live virus shot, but not with the dead virus. Am I wrong?
Developed s/s of COVID  and was brought to the ED and then admitted.  COVID testing positive.
Vaccines administered at 4:30 pm.  Developed severe eyelid swelling and diffuse urticarial rash at 7:15 pm that night.  No airway compromise.  Had also been introduced to brownie and pasta sauce that pm.  Resolved after Benadryl and 2 day course of oral steroids.
May have had a scratchy throat before 7 pm, but it was very noticeable by 7 pm. Hoarseness, couldn't lay down without getting sick because so much mucus in my throat. Slept sitting up. Lost my voice for a day. Then, ears closed up and lost my hearing in one ear, then the second ear. Never had runny nose or fever. 2 weeks later still have closed ears and ear infection. Not recovered yet.
Pt was vaccinated with the Jynneos/BN vaccine in the left forearm after completing screening (no contraindications to vaccine) with no issues. Pt walked out the door to the post-vaccination waiting area when this RN heard a thud in the hallway. Pt passed out and got a cut on his chin. Pt woke up and responded to questions. EMS was activated and pt was taken to the ER by ambulance.
Swelling, fever 103, migraine for extended days, sore arm for a week.
4cm localized inflammation to left upper extremity - no streaking noted. No fever - began morning after varicella SC injection.
Post-vaccination Guillain-Barre Syndrome (GBS) and Bell's Palsy; Post-vaccination Guillain-Barre Syndrome (GBS) and Bell's Palsy; This is a literature report for the following literature source(s):   A 10-year-old boy with postvaccination Guillain-Barre Syndrome (GBS) and Bell's Palsy. A 10-year-old boy without significant past medical history presented to the emergency room (ER) with new right facial droop two weeks following his second dose of the Pfizer COVID-19 vaccine. He was diagnosed with Bell's Palsy and received a five-day course of steroids. He returned to the ER ten days later with a four-day history of bilateral lower extremity pain, weakness, and progressively worsening gait. His examination was notable for less than antigravity strength throughout the major muscle groups of both lower limbs, in which he also had impaired light touch sensation and areflexia. Setting: Pediatric unit of acute care hospital. Cerebrospinal fluid analysis was notable for elevated protein levels. In the setting of areflexia in the bilateral lower limbs, a presumptive diagnosis of GBS was made and a 5-day course of intravenous immunoglobulin (IVIg) was initiated, with improvement. At time of discharge, he was able to ambulate independently without use of an assistive device. Both GBS and Bell's palsy have been reported following vaccinations. This case is unique in that both occurred sequentially in a pediatric patient within 1 month of the second dose of the Pfizer COVID-19 vaccine. Neurological complications of the COVID-19 vaccine include both Bell's Palsy and GBS, which as in this case, may occur sequentially. Prompt initiation of IVIg, steroids, and rehabilitation may result in good recovery. Level of Evidence: Level V.; Sender's Comments: Based on the available information, the reported serious events cannot be excluded for the suspect product  BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
experiencing pain under arm; pain under where she received injection; lymph nodes were swollen and still swollen; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (experiencing pain under arm), VACCINATION SITE PAIN (pain under where she received injection) and LYMPHADENOPATHY (lymph nodes were swollen and still swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (experiencing pain under arm), VACCINATION SITE PAIN (pain under where she received injection) and LYMPHADENOPATHY (lymph nodes were swollen and still swollen). At the time of the report, PAIN IN EXTREMITY (experiencing pain under arm), VACCINATION SITE PAIN (pain under where she received injection) and LYMPHADENOPATHY (lymph nodes were swollen and still swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, Ultrasound scan: (Inconclusive) Confirmed swollen lymph nodes.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported.  Treatment details included none
According to the patient, she woke up while sleeping to severe tingling of the nerves, backache, body pain, slight fever and upset stomach. She started feeling better by morning. Symptoms progressively got better by day 2.
Severe joint pain, chills, diarrhea, migraine headache, runny nose. Symptoms lasted approx. 48 hrs, with residual joint pain (less painful) for 5 days.
Patient felt dizzy after receiving the vaccine - monitored, and stabilized. BP 114/65, pulse 81. Standing BP 155/68.
This spontaneous report was received from a medical assistant and refers to a 65 year old patient of unknown gender. No information about the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 01-APR-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX lot # L012521 and expiration date 01-FEB-2017 (dose and route of administration were not reported). The vaccine underwent temperature excursion of 1 degree Celsius for 158 total cumulative hours, which was detected by a data logger. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Admit for COVID pneumonia. Vaccine completed June 24th. Treated w/ O2, steroids, zinc, vit-c, home dose of eliquis. Discharged with home O2.
Information has been received from a registered pharmacist concerning a 65 year old female patient with iodine and hydrochlorothiazide (+) triamterene allergy with no pertinent medical history who on 18-AUG-2010 was vaccinated IM with a 0.5 ml dose of PNEUMOVAX 23 (Lot number 665707/1407Y, exp date unknown). Concomitant medications included: LISINOPRIL (manufacturer unknown), levothyroxine sodium, SIMVASTIN (manufacturer unknown), trazodone hydrochloride and aspirin. The patient had some pain upon injection. The patient later on the same day as vaccination experienced swollen and stiff arm, redness and pain. The patient was stopped from doing activities of daily living. The patient sought medical attention by phone call on 19-AUG-2010. There was no lab diagnostic test performed. The patient applied ice and took ibuprofen. At the time of report the patient's status was recovering. No further information is available. The pharmacist would like a lot number check on 665707/1407Y. Swollen and stiff arm, redness and pain and pain upon injection were considered to be disabling. This is one of several reports from the same source. A lot check has been initiated. Additional information has been requested.
This spontaneous report was received from a pharmacist via company representative refers to a patient of unknown age and gender. No concurrent condition or medical history was reported. Recently on an unknown date in 2015, the patient was vaccinated with ZOSTAVAX (dose and route of administration not provided) for vaccination. No concomitant therapy was reported. On an unknown date in 2015, after the vaccination, the patient experienced injection site reaction that was red and inflamed (more inflamed than she normally sees). The pharmacist referred the patient to the physician. The reporter noted that the reaction subsided on an unknown date. The causality assessment was not reported. No product quality issue was involved. Additional information has been requested.
dispensed 28 doses of expired Moderna Covid-19 vaccine.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dispensed 28 doses of expired Moderna Covid-19 vaccine.) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (dispensed 28 doses of expired Moderna Covid-19 vaccine.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dispensed 28 doses of expired Moderna Covid-19 vaccine.) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Reporter reported that they dispensed 28 doses of expired Moderna Covid-19 vaccine. These were administered on 06Apr2022 & 08Apr2022 with Lot: 012H21B and expiration date:18Mar2022.  No concomitant medications were reported  No treatment medications were reported
Pain; rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) and RASH (rash) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018f21a, 006m20a and 029l20a) for COVID-19 vaccination.     Concomitant products included PREDNISONE, METOPROLOL, TAMSULOSIN and CALCIUM for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (rash). On an unknown date, the patient experienced PAIN (Pain). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN (Pain) and RASH (rash) outcome was unknown.            This case was linked to MOD-2021-392057 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: No new information received
Pt presented with c/o mild headache, transient vision w/ loss of right eye peripheral vision, bilateral extremity tingling.